May 30, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Trial of early cancer detection test misses primary endpoint; secondary data ‘promising’
CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.The NHS-Galleri trial did not meet its primary endpoint, failing to show a reduction in combined stage III/stage IV diagnoses of 12 prespecified cancer types.
1,581 words~7 min read
